STN.TO vs. IDXX
STN.TO (Stantec Inc.) and IDXX (IDEXX Laboratories, Inc.) are both stocks. STN.TO operates in Engineering & Construction (Industrials), while IDXX operates in Diagnostics & Research (Healthcare). Over the past 10 years, STN.TO returned 13.46%/yr vs 21.34%/yr for IDXX. At a 0.21 correlation, their price movements are largely independent.
Performance
STN.TO vs. IDXX - Performance Comparison
Loading charts...
Different Trading Currencies
STN.TO is traded in CAD, while IDXX is traded in USD. To make them comparable, the IDXX values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, STN.TO achieves a -20.63% return, which is significantly lower than IDXX's -15.54% return. Over the past 10 years, STN.TO has underperformed IDXX with an annualized return of 13.46%, while IDXX has yielded a comparatively higher 21.34% annualized return.
STN.TO
- 1D
- -0.36%
- 1M
- -14.21%
- YTD
- -20.63%
- 6M
- -22.25%
- 1Y
- -29.01%
- 3Y*
- 8.82%
- 5Y*
- 14.98%
- 10Y*
- 13.46%
IDXX
- 1D
- 0.10%
- 1M
- 2.27%
- YTD
- -15.54%
- 6M
- -19.96%
- 1Y
- 9.08%
- 3Y*
- 9.11%
- 5Y*
- 2.66%
- 10Y*
- 21.34%
STN.TO vs. IDXX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
STN.TO Stantec Inc. | -20.63% | 15.61% | 6.81% | 65.43% | -7.62% | 74.09% | 14.27% | 24.95% | -13.44% | 5.18% |
IDXX IDEXX Laboratories, Inc. | -15.54% | 56.16% | -19.21% | 32.82% | -34.12% | 31.66% | 86.88% | 34.59% | 28.96% | 24.32% |
Correlation
The correlation between STN.TO and IDXX is 0.26, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.26 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.28 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.32 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Jul 7, 2006 | 0.21 |
The correlation between STN.TO and IDXX shifts across timeframes, from 0.21 (all time) to 0.32 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
STN.TO:
CA$4.30
IDXX:
$18.08
STN.TO:
23.88
IDXX:
31.04
STN.TO:
1.00
IDXX:
2.68
STN.TO:
1.48
IDXX:
7.65
STN.TO:
CA$7.92B
IDXX:
$4.45B
STN.TO:
CA$3.40B
IDXX:
$2.76B
STN.TO:
CA$1.13B
IDXX:
$1.52B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
STN.TO vs. IDXX — Risk / Return Rank
STN.TO
IDXX
STN.TO vs. IDXX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Stantec Inc. (STN.TO) and IDEXX Laboratories, Inc. (IDXX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| STN.TO | IDXX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.28 | ||
| Sortino ratioReturn per unit of downside risk | -2.18 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 1.10 | -0.28 |
| Calmar ratioReturn relative to maximum drawdown | -0.79 | 0.28 | -1.07 |
| Martin ratioReturn relative to average drawdown | -1.77 | 0.56 | -2.33 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| STN.TO | IDXX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.05 | 0.22 | -1.28 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | 0.63 | 0.08 | +0.56 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.57 | 0.64 | -0.07 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.46 | 0.63 | -0.16 |
Drawdowns
STN.TO vs. IDXX - Drawdown Comparison
The maximum STN.TO drawdown since its inception was -58.12%, which is greater than IDXX's maximum drawdown of -52.40%. Use the drawdown chart below to compare losses from any high point for STN.TO and IDXX.
Loading charts...
Drawdown Indicators
| STN.TO | IDXX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -58.12% | -52.40% | -5.72% |
Max Drawdown (1Y)Largest decline over 1 year | -36.84% | -33.06% | -3.78% |
Max Drawdown (3Y)Largest decline over 3 years | -36.84% | -34.35% | -2.49% |
Max Drawdown (5Y)Largest decline over 5 years | -36.84% | -52.40% | +15.56% |
Max Drawdown (10Y)Largest decline over 10 years | -36.84% | -52.40% | +15.56% |
Current DrawdownCurrent decline from peak | -35.14% | -27.66% | -7.48% |
Average DrawdownAverage peak-to-trough decline | -13.03% | -12.36% | -0.67% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 16.42% | 16.30% | +0.12% |
Volatility
STN.TO vs. IDXX - Volatility Comparison
Stantec Inc. (STN.TO) has a higher volatility of 13.38% compared to IDEXX Laboratories, Inc. (IDXX) at 8.65%. This indicates that STN.TO's price experiences larger fluctuations and is considered to be riskier than IDXX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| STN.TO | IDXX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 13.38% | 8.65% | +4.73% |
Volatility (6M)Calculated over the trailing 6-month period | 23.66% | 20.06% | +3.60% |
Volatility (1Y)Calculated over the trailing 1-year period | 27.65% | 41.17% | -13.52% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 23.76% | 35.55% | -11.79% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.86% | 33.52% | -9.66% |
Dividends
STN.TO vs. IDXX - Dividend Comparison
STN.TO's dividend yield for the trailing twelve months is around 0.90%, while IDXX has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
IDXX IDEXX Laboratories, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
STN.TO Stantec Inc. | 0.90% | 0.69% | 0.74% | 0.73% | 1.11% | 0.93% | 1.50% | 1.58% | 1.84% | 1.42% | 1.33% | 1.22% |
Financials
STN.TO vs. IDXX - Financials Comparison
This section allows you to compare key financial metrics between Stantec Inc. and IDEXX Laboratories, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
STN.TO vs. IDXX - Profitability Comparison
STN.TO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Stantec Inc. reported a gross profit of 819.30M and revenue of 2.07B. Therefore, the gross margin over that period was 39.6%.
IDXX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a gross profit of 722.74M and revenue of 1.14B. Therefore, the gross margin over that period was 63.4%.
STN.TO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Stantec Inc. reported an operating income of 174.60M and revenue of 2.07B, resulting in an operating margin of 8.4%.
IDXX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported an operating income of 362.59M and revenue of 1.14B, resulting in an operating margin of 31.8%.
STN.TO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Stantec Inc. reported a net income of 110.80M and revenue of 2.07B, resulting in a net margin of 5.4%.
IDXX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, IDEXX Laboratories, Inc. reported a net income of 278.45M and revenue of 1.14B, resulting in a net margin of 24.4%.
Frequently Asked Questions
STN.TO and IDXX have a correlation of 0.26, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for STN.TO and IDXX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer